203 related articles for article (PubMed ID: 36265088)
21. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure.
Wong FL; Bhatia S; Landier W; Francisco L; Leisenring W; Hudson MM; Armstrong GT; Mertens A; Stovall M; Robison LL; Lyman GH; Lipshultz SE; Armenian SH
Ann Intern Med; 2014 May; 160(10):672-83. PubMed ID: 24842414
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
Cott Chubiz JE; Lee JM; Gilmore ME; Kong CY; Lowry KP; Halpern EF; McMahon PM; Ryan PD; Gazelle GS
Cancer; 2013 Mar; 119(6):1266-76. PubMed ID: 23184400
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density.
Pataky R; Ismail Z; Coldman AJ; Elwood M; Gelmon K; Hedden L; Hislop G; Kan L; McCoy B; Olivotto IA; Peacock S
J Med Screen; 2014 Dec; 21(4):180-8. PubMed ID: 25186116
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness of Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors Treated with Procarbazine and/or Infradiaphragmatic Radiotherapy.
Ykema BLM; Gini A; Rigter LS; Spaander MCW; Moons LMG; Bisseling TM; de Boer JP; Verbeek WHM; Lugtenburg PJ; Janus CPM; Petersen EJ; Roesink JM; van der Maazen RWM; ; Aleman BMP; Meijer GA; van Leeuwen FE; Snaebjornsson P; Carvalho B; van Leerdam ME; Lansdorp-Vogelaar I
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2157-2168. PubMed ID: 36166472
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging.
Tieu MT; Cigsar C; Ahmed S; Ng A; Diller L; Millar BA; Crystal P; Hodgson DC
Cancer; 2014 Aug; 120(16):2507-13. PubMed ID: 24888639
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the Benefits and Cost-Effectiveness of Population-Based Breast Cancer Screening in Urban China: A Model-Based Analysis.
Wang J; Greuter MJW; Zheng S; van Veldhuizen DWA; Vermeulen KM; Wang Y; Lu W; de Bock GH
Int J Health Policy Manag; 2022 Sep; 11(9):1658-1667. PubMed ID: 34273933
[TBL] [Abstract][Full Text] [Related]
28. Economic potential of abbreviated breast MRI for screening women with dense breast tissue for breast cancer.
Tollens F; Baltzer PAT; Dietzel M; Schnitzer ML; Schwarze V; Kunz WG; Rink J; Rübenthaler J; Froelich MF; Schönberg SO; Kaiser CG
Eur Radiol; 2022 Nov; 32(11):7409-7419. PubMed ID: 35482122
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.
Lee JM; McMahon PM; Kong CY; Kopans DB; Ryan PD; Ozanne EM; Halpern EF; Gazelle GS
Radiology; 2010 Mar; 254(3):793-800. PubMed ID: 20177093
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
Comstock CE; Gatsonis C; Newstead GM; Snyder BS; Gareen IF; Bergin JT; Rahbar H; Sung JS; Jacobs C; Harvey JA; Nicholson MH; Ward RC; Holt J; Prather A; Miller KD; Schnall MD; Kuhl CK
JAMA; 2020 Feb; 323(8):746-756. PubMed ID: 32096852
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.
Sankatsing VD; Heijnsdijk EA; van Luijt PA; van Ravesteyn NT; Fracheboud J; de Koning HJ
Int J Cancer; 2015 Oct; 137(8):1990-9. PubMed ID: 25895135
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.
Chen AB; Punglia RS; Kuntz KM; Mauch PM; Ng AK
J Clin Oncol; 2009 Nov; 27(32):5383-9. PubMed ID: 19752333
[TBL] [Abstract][Full Text] [Related]
33. Finding the optimal mammography screening strategy: A cost-effectiveness analysis of 920 modelled strategies.
Kregting LM; Sankatsing VDV; Heijnsdijk EAM; de Koning HJ; van Ravesteyn NT
Int J Cancer; 2022 Jul; 151(2):287-296. PubMed ID: 35285018
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study.
Chung WS; Wan TTH; Shiu YT; Shi HY
J Epidemiol Glob Health; 2024 May; ():. PubMed ID: 38748377
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness simulation and analysis of colorectal cancer screening in Hong Kong Chinese population: comparison amongst colonoscopy, guaiac and immunologic fecal occult blood testing.
Wong CK; Lam CL; Wan YF; Fong DY
BMC Cancer; 2015 Oct; 15():705. PubMed ID: 26471036
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness of screening mammography in a low income country: a Markov simulation analysis.
Kejela S
BMC Med Imaging; 2021 Nov; 21(1):162. PubMed ID: 34727883
[TBL] [Abstract][Full Text] [Related]
38. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
39. Cost-effectiveness of alternative strategies for integrating MRI into breast cancer screening for women at high risk.
Ahern CH; Shih YC; Dong W; Parmigiani G; Shen Y
Br J Cancer; 2014 Oct; 111(8):1542-51. PubMed ID: 25137022
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province.
Shi J; Guan Y; Liang D; Li D; He Y; Liu Y
Sci Rep; 2023 Feb; 13(1):3370. PubMed ID: 36849794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]